Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia

Ítems similars

• Treatment-free remission in FIP1L1-PDGFRA–positive myeloid/lymphoid neoplasms with eosinophilia after imatinib discontinuation
  per: Metzgeroth, Georgia, et al.
  Publicat: (2020)
• Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis
  per: Erben, Philipp, et al.
  Publicat: (2010)
• Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1
  per: Bain, Barbara J.
  Publicat: (2010)
• An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis
  per: Riffel, Philipp, et al.
  Publicat: (2020)
• The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
  per: Jawhar, Mohamad, et al.
  Publicat: (2017)